FDA Approves First Biosimilar
March 12, 2015 - BioPharm Intl.
Mar 06, 2015
By Randi Hernandez
BioPharm International
Finding Opportunities in Brazil
March 12, 2015 - BioPharm Intl.
Feb 06, 2015
By Hellen Berger
BioPharm International
Volume 28, Issue 2
SEC in the Modern Downstream Purification Process
March 12, 2015 - BioPham Intl.
Mar 01, 2015
By R. Christopher Manzari, J. Kevin O'Donnell
BioPharm International
Volume 3, Issue 28
Tackling Analytical Method Development for ADCs
March 12, 2015 - BioPharm Intl.
Feb 01, 2015
By Cynthia Challener, PhD
BioPharm International
Volume 28, Issue 2
Quality by Design and Extractable and Leachable Testing
February 26, 2015 - BioPharm Intl.
The author discusses the various ways in which a quality-by-design program can enhance the extractable and leachable assessment of a drug product.
…
The Bullish Outlook for Biosimilars
February 26, 2015 - BioPharm Intl.
Feb 01, 2015
By Jill E. Sackman, PhD, Michael J. Kuchenreuther, PhD
BioPharm International
There are several impo
Labeling of Biosimilars
February 26, 2015 - BioPharm Intl.
EMA is under pressure to exert even tighter standards on biosimilars being marketed in Europe.
Feb 01, 2015
By Sean Milmo
Fermentation for the Future
January 30, 2015 - BioPharm International
Improving efficiency, value chain, quality, and protein complexity with advanced bioprocess development.
Jan 01, 2015
Ligand-Binding Assays and the Determination of Biosimilarity
January 29, 2015 - BioPharm Intl.
Implementation of Raw Material Control Strategies in the Manufact
January 29, 2015 - BioPharm International
The authors review efforts to limit polymer degradation without significantly impeding cell growth.
Jan 01, 2015